Literature DB >> 34626131

Cardiolipin function in the yeast S. cerevisiae and the lessons learned for Barth syndrome.

Jiajia Ji1, Miriam L Greenberg1.   

Abstract

Cardiolipin (CL) is the signature phospholipid (PL) of mitochondria and plays a pivotal role in mitochondrial and cellular function. Disruption of the CL remodeling gene tafazzin (TAZ) causes the severe genetic disorder Barth syndrome (BTHS). Our current understanding of the function of CL and the mechanism underlying the disease has greatly benefited from studies utilizing the powerful yeast model Saccharomyces cerevisiae. In this review, we discuss important findings on the function of CL and its remodeling from yeast studies and the implications of these findings for BTHS, highlighting the potential physiological modifiers that may contribute to the disparities in clinical presentation among BTHS patients.
© 2021 SSIEM.

Entities:  

Keywords:  Barth syndrome; cardiolipin; mitochondrial disease; tafazzin; yeast

Mesh:

Substances:

Year:  2021        PMID: 34626131      PMCID: PMC8755574          DOI: 10.1002/jimd.12447

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  140 in total

1.  Cardiolipin stabilizes respiratory chain supercomplexes.

Authors:  Kathy Pfeiffer; Vishal Gohil; Rosemary A Stuart; Carola Hunte; Ulrich Brandt; Miriam L Greenberg; Hermann Schägger
Journal:  J Biol Chem       Date:  2003-10-15       Impact factor: 5.157

Review 2.  The key role of anaplerosis and cataplerosis for citric acid cycle function.

Authors:  Oliver E Owen; Satish C Kalhan; Richard W Hanson
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

3.  The composition of cardiolipin.

Authors:  M C PANGBORN
Journal:  J Biol Chem       Date:  1947-04       Impact factor: 5.157

4.  A mitochondrial phosphatase required for cardiolipin biosynthesis: the PGP phosphatase Gep4.

Authors:  Christof Osman; Mathias Haag; Felix T Wieland; Britta Brügger; Thomas Langer
Journal:  EMBO J       Date:  2010-05-18       Impact factor: 11.598

5.  Cardiolipin-induced activation of pyruvate dehydrogenase links mitochondrial lipid biosynthesis to TCA cycle function.

Authors:  Yiran Li; Wenjia Lou; Vaishnavi Raja; Simone Denis; Wenxi Yu; Michael W Schmidtke; Christian A Reynolds; Michael Schlame; Riekelt H Houtkooper; Miriam L Greenberg
Journal:  J Biol Chem       Date:  2019-06-11       Impact factor: 5.157

6.  Overexpression of branched-chain amino acid aminotransferases rescues the growth defects of cells lacking the Barth syndrome-related gene TAZ1.

Authors:  Diana Antunes; Arpita Chowdhury; Abhishek Aich; Sreedivya Saladi; Nofar Harpaz; Mark Stahl; Maya Schuldiner; Johannes M Herrmann; Peter Rehling; Doron Rapaport
Journal:  J Mol Med (Berl)       Date:  2019-01-03       Impact factor: 4.599

7.  Isolation and inactivation of the nuclear gene encoding the rotenone-insensitive internal NADH: ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae.

Authors:  C A Marres; S de Vries; L A Grivell
Journal:  Eur J Biochem       Date:  1991-02-14

8.  Absence of cardiolipin results in temperature sensitivity, respiratory defects, and mitochondrial DNA instability independent of pet56.

Authors:  Quan Zhong; Vishal M Gohil; Lining Ma; Miriam L Greenberg
Journal:  J Biol Chem       Date:  2004-05-29       Impact factor: 5.157

9.  Mitochondria-ros crosstalk in the control of cell death and aging.

Authors:  Saverio Marchi; Carlotta Giorgi; Jan M Suski; Chiara Agnoletto; Angela Bononi; Massimo Bonora; Elena De Marchi; Sonia Missiroli; Simone Patergnani; Federica Poletti; Alessandro Rimessi; Jerzy Duszynski; Mariusz R Wieckowski; Paolo Pinton
Journal:  J Signal Transduct       Date:  2011-11-14

10.  A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism.

Authors:  W Reid Thompson; Brittany Hornby; Ryan Manuel; Elena Bradley; Janice Laux; Jim Carr; Hilary J Vernon
Journal:  Genet Med       Date:  2020-10-20       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.